Search research articles
Contact Us
Filters
Showing results (41-50 of 105) with videos related to
Page
of 11
Sort By:
European Urology Open Science
|
December 25, 2024
High Detection Rates for Prostate-specific Membrane Antigen-avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography
Sarah Thomas, Jason Callahan, Paul Conway, et al.
ANZ Journal of Surgery
|
May 18, 2017
The Australian laparoscopic radical prostatectomy learning curve
Marcus Handmer, Charles Chabert, Ronald Cohen, et al.
BMC Urology
|
February 5, 2021
A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance
Samuel W D Merriel, Daniel Moon, Phil Dundee, et al.
BJU International
|
May 16, 2022
Prostate-specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer
Jonathan S O'Brien, Aoife McVey, Brian D Kelly, et al.
BJU International
|
January 23, 2024
Indocyanine green in minimally and maximally invasive genitourinary cancer surgery
David C Chen, Devan S Sandhu, Jonathan S O'Brien, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
May 21, 2024
AAPM&R consensus guidance on spasticity assessment and management
Monica Verduzco-Gutierrez, Preeti Raghavan, Jessica Pruente, et al.
BJU International
|
April 1, 2022
High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer
Gideon Ptasznik, Nathan Papa, Brian D Kelly, et al.
European Urology
|
June 15, 2017
Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review
Christopher J D Wallis, Adam Glaser, Jim C Hu, et al.
Scientific Reports
|
November 10, 2022
A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis
Jang Woo Ha, Yoo Jin Hong, Hyun Jin Cha, et al.
The Journal of Urology
|
September 21, 2021
<sup>68</sup>Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography Maximum Standardized Uptake Value as a Predictor of Gleason Pattern 4 and Pathological Upgrading in Intermediate-Risk Prostate Cancer
Alan L Xue, Arveen A Kalapara, Zita E Ballok, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 105) with videos related to
Sort By:
Page
of 11
European Urology Open Science
|
December 25, 2024
High Detection Rates for Prostate-specific Membrane Antigen-avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography
Sarah Thomas, Jason Callahan, Paul Conway, et al.
ANZ Journal of Surgery
|
May 18, 2017
The Australian laparoscopic radical prostatectomy learning curve
Marcus Handmer, Charles Chabert, Ronald Cohen, et al.
BMC Urology
|
February 5, 2021
A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance
Samuel W D Merriel, Daniel Moon, Phil Dundee, et al.
BJU International
|
May 16, 2022
Prostate-specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer
Jonathan S O'Brien, Aoife McVey, Brian D Kelly, et al.
BJU International
|
January 23, 2024
Indocyanine green in minimally and maximally invasive genitourinary cancer surgery
David C Chen, Devan S Sandhu, Jonathan S O'Brien, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
May 21, 2024
AAPM&R consensus guidance on spasticity assessment and management
Monica Verduzco-Gutierrez, Preeti Raghavan, Jessica Pruente, et al.
BJU International
|
April 1, 2022
High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer
Gideon Ptasznik, Nathan Papa, Brian D Kelly, et al.
European Urology
|
June 15, 2017
Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review
Christopher J D Wallis, Adam Glaser, Jim C Hu, et al.
Scientific Reports
|
November 10, 2022
A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis
Jang Woo Ha, Yoo Jin Hong, Hyun Jin Cha, et al.
The Journal of Urology
|
September 21, 2021
<sup>68</sup>Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography Maximum Standardized Uptake Value as a Predictor of Gleason Pattern 4 and Pathological Upgrading in Intermediate-Risk Prostate Cancer
Alan L Xue, Arveen A Kalapara, Zita E Ballok, et al.
Page
of 11